Abstract
Smoking is related to decreased bone mass and increased risk of osteoporotic fractures. However, the harmful effects of smoking on bone have not been well characterized. The purpose of this study was to assess the repercussions of smoking on bone mass in premenopausal women, and the relationship between these effects and parameters of mineral metabolism and hormone profile. We measured bone mineral density (BMD) in 101 premenopausal women (47 smokers, 54 nonsmokers) with dualenergy X-ray absorptiometry (DeXA) of the proximal femur and lumbar spine. In a subgroup of the sample (16 smokers, 15 nonsmokers) we measured biochemical indicators of mineral metabolism and hormone profile. BMD in the femoral neck, Ward's triangle, and the intertrochanter region was significantly lower in smoker (P<0.05) than in nonsmokers. Concentrations of sex hormone-binding globulin were higher, and free testosterone index (FTI) was lower (P<0.05) in smokers. We found no significant differences between the groups in parameters of mineral metabolism. Concentrations of dehydroepiandrosterone sulfate and free testosterone index were directly correlated with values of BMD in different sites. Our findings show that smoking by premenopausal women is associated with decreased BMD and characteristic changes in the hormone profile.
Similar content being viewed by others
References
Daniell HW (1972) Osteoporosis and smoking. JAMA 221:509
Daniell HW (1976) Osteoporosis of the slender smokers. Vertebral compression fractures and loss of metacarpal cortex in relation to postmenopausal cigarette smoking and lack of obesity. Arch Int Med 136:298–395
Seeman E, Melton LJ III, O'Fallon WM, Riggs BL (1989) Risk factors for spinal osteoporosis in men. Am J Med 320:554–558
Aloia JP, Vasmani AN, Yeh JK (1983) Determinants of bone mass in postmenopausal women. Arch Intern Med 143:1700–1704
Williams AR, Weiss NS, Ure CL, Ballard J, Daling J (1982) Effect of weight, smoking and estrogen use on the risk of hip and forearm fractures in postmenopausal women. Obstet Gynecol 60:695–699
McNair, Christiansen MS, Madsbad S, Christiansen C, Binder C, Transbol I (1980) Bone loss in patients with diabetes mellitus. Effects of smoking. Min Elect Metab 3:94–97
Sparrow D, Rosner B, Garvey A, Silbert J (1982) The influence of cigarette and age on bone loss in women. Arch Environ Health 37:246–249
Stevenson JC, Lees B, Devenport M, Cust MP, Ganger KF (1989) Determinants of bone density in normal women: risk factors for future osteoporosis? Br Med J 298:924–928
Davis MC, Hall MC, Jacobs HAS (1990) Bone mineral loss in young women with amenorrhoea. Br Med J 301:790–793
Jensen GF (1986) Osteoporosis of the slender smokers revisited by epidemiologic approach. Eur J Clin Invest 16:239–242
McDermott MT, Witte MC (1988) Bone mineral content in smokers. South Med J 81:477–480
Daniel M, Martin AD, Drinkwater DT (1992) Cigarette smoking, steroid hormones, and bone mineral density in young women. Calcif Tissue Int 50:300–305
MacMahon E, Trichopaulos D, Cole P, Brown J (1982) Cigarette smoking and urinary estrogens. N Engl J Med 07:1062–1065
Michnovicz PJ, Herchcopf RJ, Naganuma H, Bradlow HL, Fishman J (1986) Increased 2-hydroxylation of estradiol as a possible mechanism for anti-estrogenic effect of cigarette smoking. N Engl J Med 315:1305–1309
De Vernejoul MC, Bielakoff J, Gueris J, Hott M, Modrovski D, Kuntz D, Miravet L, Ryckewaert A (1983) Evidence for defective osteoblastic function. A role for alcohol and tobacco consumption in osteoporosis in middle-aged men. Clin Orthop 179: 107–115
Fang MA, Frost PJ, Iida-Klein A, Hahn TJ (1991) Effects of nicotine on cellular function in UMR 106-01 osteoblast-like cells. Bone 12:283–286
Hollo I, Gergely I, Boross M (1987) Smoking results in calcitonin resistance. JAMA 237:2470
Belgorosky A, Escobar ME, Ravirola MA (1987) Validity of the calculation of non-sex hormone-binding globulin-bound estradiol from total testosterone, total estradiol and sex hormone-binding globulin concentrations in human serum. Steroid Biochem 28:429–432
Campos-Pastor MM, Muñoz-Torres M, Escobar-Jimenez E, Ruiz de Almodovar M, Jódar-Gimeno E (1993) Bone mass in females with different thyroid disorders: influence of menopausal status. Bone Miner 21:1–8
Slemenda C, Hui SL, Longcope C, Johnston CC (1989) Cigarette smoking, obesity, and bone mass. J Bone Miner Res 4: 737–741
Mazess RB, Barden HS (1991) Bone density in premenopausal women: effects of age, dietary intake, physical activity, smoking and birth control pills. Am J Clin Nutr 53:132–142
Krall EA, Dawson-Hughes B (1991) Smoking and bone loss among postmenopausal women. J Bone Miner Res 6:331–337
Pocock NA, Eisman JA, Kelly PJ, Smabrook PN, Yeates MG (1989) Effects of tobacco use on axial and appendicular bone mineral density. Bone 10:329–331
Ernster VL (1981) The epidemiology of benign breast disease. Epidemiol Rev 3:184–202
Berkowitz GS, Canny FP, Li Volsvi VA (1985) Cigarette smoking and benign breast disease. J Epidemiol Commun Health 39:308–313
Lesko SM, Rosenberg L, Kaufmar DN (1985) Cigarette smoking and the risk of endometrial cancer (1985) N Engl J Med 313:593–596
Kountmartaki Y, Tzonou A, Koumantakis E (1989) A case control study of cancer of endometrium in Athens. Int J Cancer 43:795–799
Nordin BEC, Need AG, Morris HA, Horrowitz M (1985) New approaches to the problems of osteoporosis. Clin Orthop 200: 181–197
Jensen J, Christiansen C, Rødbro P Cigarette smoking, serum estrogens and bone loss during hormone-replacement therapy after menopause. N Engl J Med 313:973–975
Daniell HW (1987) Anti-estrogenic effect of cigarette smoking. N Engl J Med 316:1342–1343
Kiel DP, Baron JA, Andersson J, Hannan MT, Felson DT (1992) Smoking eliminates the protective effect of oral estrogens on the risk for hip fracture among women. Ann Int Med 116: 716–721
Moore JW, Key TJA, Bulbrook RD, Clark GMG, Allen DS, Wang DY, Pike MC (1987) Sex hormone binding globulin and risk factor for breast cancer in a population of normal women who had never used exogenous sex hormones. Br J Obstet Gynecol 56:661–666
Nisker JA, Hammond GL, Siiters PK (1980) More on fatness and reproduction. N Engl J Med 303:1124
Vermeulen A, Verdonck L, Van Der Staten M, Orie N (1969) Capacity of the testosterone-binding globulin in human plasma and influence of specific binding of testosterone on its metabolic clearance rate. J Clin Endocrinol Metab 29:1470–1477
Buchanan JR, Hospodar P, Myers C, Leuenberg P, Demers LM (1988) Effect of excess endogenous androgens on bone density in young women. J Clin Endocrinol Metab 67:937–943
Preželj J, Kocijančič A (1993) Bone mineral density in hyperandrogenic amenorrhoea. Calcif Tissue Int 52:422–424
Steinberg KK, Freni-Titulaer LW, DePuey EG, Miller DT, Sgoutas DS, Coralli CH, Phillips DL, Rogers TN, Clark RV (1989) Sex steroids and bone density in premenopausal and perimenopausal women. J Clin Endocrinol Metab 69:533–539
Van Hemert AM, Birkenhäger JC, De Joung FH, Vanderbroucke JP, Valkenburg HA (1989) Sex hormone binding globulin in postmenopausal women: a predictor of osteoporosis superior to endogenous oestrogens. Clin Endocrinol 31:499–509
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ortego-Centeno, N., Muñoz-Torres, M., Hernandez-Quero, J. et al. Bone mineral density, sex steroids, and mineral metabolism in premenopausal smokers. Calcif Tissue Int 55, 403–407 (1994). https://doi.org/10.1007/BF00298551
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00298551